Their mechanism of action involves impairing glucose uptake in tumor cells by targeting SGLT1, SGLT2, or GLUT1 transporters, disrupting cellular energy production, and triggering AMPK/mTOR signaling, which suppresses cell growth [138]. Here, SLC5A2 is linked to neoplasm.